Package 50090-4747-2

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 50090-4747-2
Digits Only 5009047472
Product NDC 50090-4747
Description

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4747-2)

Marketing

Marketing Status
Marketed Since 2019-11-22
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "238517b6-07f6-40c8-9b93-d75e839265a8", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["6902b252-dc69-4b3c-bad2-b6667a5f6d84"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4747-0)", "package_ndc": "50090-4747-0", "marketing_start_date": "20191122"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4747-1)", "package_ndc": "50090-4747-1", "marketing_start_date": "20191122"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4747-2)", "package_ndc": "50090-4747-2", "marketing_start_date": "20191122"}], "brand_name": "Bupropion Hydrochloride", "product_id": "50090-4747_238517b6-07f6-40c8-9b93-d75e839265a8", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-4747", "generic_name": "Bupropion Hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20170614", "listing_expiration_date": "20271231"}